No black box warning on record for Trihexyphenidyl Hydrochloride

As of the latest FDA labeling reviewed, Trihexyphenidyl Hydrochloride (TRIHEXYPHENIDYL HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Trihexyphenidyl Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Patients to be treated with trihexyphenidyl should have a gonioscope evaluation prior to initiation of therapy and close monitoring of intraocular pressures. The use of anticholinergic drugs may precipitate angle closure with an increase in intraocular pressure. If blurring of vision occurs during therapy, the possibility of narrow angle glaucoma should be considered. Blindness has been r

No black box warning on record for Trihexyphenidyl Hydrochloride

Other warnings & precautions

WARNINGS Patients to be treated with trihexyphenidyl should have a gonioscope evaluation prior to initiation of therapy and close monitoring of intraocular pressures. The use of anticholinergic drugs may precipitate angle closure with an increase in intraocular pressure. If blurring of vision occurs during therapy, the possibility of narrow angle glaucoma should be considered. Blindness has been r

Trihexyphenidyl Hydrochloride Black Box Warning

No black box warning on record for Trihexyphenidyl Hydrochloride

Other warnings & precautions

Trihexyphenidyl Hydrochloride Black Box Warning

No black box warning on record for Trihexyphenidyl Hydrochloride

Other warnings & precautions